Amethyst and Stingray form Europe’s Largest oncology platform
Pan-European mid-market investment firm Fremman Capital has acquired Stingray Healthcare from Jacobs Capital to merge it with Amethyst Healthcare, creating Europe’s largest independent cancer care platform . The transaction unites two complementary oncology networks with a shared mission to expand access to high-quality, patient-centred radiotherapy services across Western and Central Europe. The merger leverages Amethyst’s established footprint in France, Poland,…